Yumin Dai, José A Santiago-Rivera, Stefan Hargett, Joseph M Salamoun, Kyle L Hoehn, Webster L Santos
Bioorganic & medicinal chemistry letters 2022 Oct 01We report new mitochondrial uncouplers derived from the conversion of [1,2,5]oxadiazolo[3,4-b]pyrazines to 1H-imidazo[4,5-b]pyrazines. The in situ Fe-mediated reduction of the oxadiazole fragment followed by cyclization gave access to imidazopyrazines in moderate to good yields. A selection of orthoesters also allowed functionalization on the 2-position of the imidazole ring. This method afforded a variety of imidazopyrazine derivatives with varying substitution on the 2, 5 and 6 positions. Our studies suggest that both a 2-trifluoromethyl group and N-methylation are crucial for mitochondrial uncoupling capacity. Copyright © 2022 Elsevier Ltd. All rights reserved.
Yumin Dai, José A Santiago-Rivera, Stefan Hargett, Joseph M Salamoun, Kyle L Hoehn, Webster L Santos. Conversion of oxadiazolo[3,4-b]pyrazines to imidazo[4,5-b]pyrazines via a tandem reduction-cyclization sequence generates new mitochondrial uncouplers. Bioorganic & medicinal chemistry letters. 2022 Oct 01;73:128912
PMID: 35907607
View Full Text